{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "9914446", "DateCompleted": {"Year": "1999", "Month": "03", "Day": "12"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "14"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0006-8993", "JournalIssue": {"Volume": "818", "Issue": "1", "PubDate": {"Year": "1999", "Month": "Feb", "Day": "06"}}, "Title": "Brain research", "ISOAbbreviation": "Brain Res"}, "ArticleTitle": "Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptors.", "Pagination": {"StartPage": "135", "EndPage": "139", "MedlinePgn": "135-9"}, "Abstract": {"AbstractText": ["Pretreatment of rats with the extract of Ginkgo biloba termed EGb761 reduced the behavioral sensitization induced by successive D-amphetamine administrations (0.5 mg/kg) as estimated by increasing values of locomotor activity. EGb761 pretreatment also prevented the reduced density of [3H]dexamethasone binding sites in the dentate gyrus and the CA1 hippocampal regions of D-amphetamine treated animals. These observations suggest that EGb761, by reducing glucocorticoid levels, could modulate the activity of the neuronal systems involved in the expression of the behavioral sensitization."], "CopyrightInformation": "Copyright 1999 Elsevier Science B.V."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Psypharm, BP 5, 53001 Laval Cedex, France."}], "Identifier": [], "LastName": "Trovero", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brochet", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tassin", "ForeName": "J P", "Initials": "JP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Drieu", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Brain Res", "NlmUniqueID": "0045503", "ISSNLinking": "0006-8993"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Steroid"}, {"RegistryNumber": "19FUJ2C58T", "NameOfSubstance": "Ginkgo biloba extract"}, {"RegistryNumber": "CK833KGX7E", "NameOfSubstance": "Amphetamine"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Amphetamine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Dentate Gyrus"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Steroid"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "1", "Day": "23"}, {"Year": "1999", "Month": "1", "Day": "23", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "1", "Day": "23", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9914446", "10.1016/s0006-8993(98)01151-2", "S0006-8993(98)01151-2"]}}], "PubmedBookArticle": []}